Organigram Holdings Inc. (TSE:OGI – Get Free Report) Director James Hideo Yamanaka purchased 20,000 shares of Organigram stock in a transaction dated Friday, May 22nd. The stock was acquired at an average price of C$1.10 per share, for a total transaction of C$22,000.00. Following the completion of the transaction, the director owned 20,000 shares in the company, valued at approximately C$22,000. The trade was a ∞ increase in their position.
Organigram Trading Down 3.1%
Organigram stock opened at C$1.55 on Wednesday. The firm’s 50-day moving average is C$1.84 and its 200-day moving average is C$2.07. The company has a debt-to-equity ratio of 2.20, a quick ratio of 2.62 and a current ratio of 2.82. Organigram Holdings Inc. has a 1 year low of C$1.44 and a 1 year high of C$3.09. The company has a market cap of C$218.20 million, a P/E ratio of -7.24, a PEG ratio of 0.42 and a beta of 1.72.
Wall Street Analyst Weigh In
Several analysts recently issued reports on OGI shares. Canaccord Genuity Group set a C$3.00 price target on Organigram and gave the stock a “buy” rating in a report on Tuesday, January 27th. ATB Cormark Capital Markets downgraded Organigram from a “strong-buy” rating to a “moderate buy” rating and cut their price target for the stock from C$3.50 to C$3.25 in a report on Wednesday, February 11th. Two equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of C$3.13.
About Organigram
Organigram Inc is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.
Featured Articles
- Five stocks we like better than Organigram
- Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
- 2 Aluminum Stocks Poised for Big Tariff-Related Gains
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.
